BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37434155)

  • 1. High expression of IL4I1 is correlated with poor prognosis and immune infiltration in thyroid cancer.
    Zhu L; Wang J; Hu J
    BMC Endocr Disord; 2023 Jul; 23(1):148. PubMed ID: 37434155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis of prognostic and immunological role of IL4I1 in human tumors: a bulk omics research and single cell sequencing validation.
    Chen B; Liu Y; He Y; Shen C
    Discov Oncol; 2024 May; 15(1):139. PubMed ID: 38691253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
    Lu G; Zhou Y; Zhang C; Zhang Y
    Front Genet; 2021; 12():671585. PubMed ID: 34149814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy.
    Ye F; Wang L; Li Y; Dong C; Zhou L; Xu J
    Front Immunol; 2023; 14():1338244. PubMed ID: 38250074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
    Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
    Front Immunol; 2022; 13():967277. PubMed ID: 36466837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer analysis combined with experimental validation revealed IL4I1 as an immunological and prognostic biomarker.
    Rao D; Yu C; Wang T; Sheng J; Lv E; Liang H; Huang W; Dong H
    Int Immunopharmacol; 2022 Oct; 111():109091. PubMed ID: 35952516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients.
    Jiao M; Sun W; Li L; Li C; Zhou J; Li Q; Duan L
    Front Genet; 2022; 13():878123. PubMed ID: 36246613
    [No Abstract]   [Full Text] [Related]  

  • 11. IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer.
    Peng X; Liu C; Zhang L; Chen Y; Mao L; Gao S; Shi X; Zuo L
    Front Pharmacol; 2024; 15():1365683. PubMed ID: 38873416
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
    Wang D; Wang QH; Luo T; Jia W; Wang J
    World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCDC134 as a Prognostic-Related Biomarker in Breast Cancer Correlating With Immune Infiltrates.
    Huang Z; Yang L; Chen J; Li S; Huang J; Chen Y; Liu J; Wang H; Yu H
    Front Oncol; 2022; 12():858487. PubMed ID: 35311121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
    Tang X; Zhou H; Liu Y
    Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer.
    Ren X; Du H; Cheng W; Wang Y; Xu Y; Yan S; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():997873. PubMed ID: 36407322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma.
    Yan J; Xie X; Li Q; Liang P; Zhang J; Xu G
    Heliyon; 2023 Feb; 9(2):e13613. PubMed ID: 36852051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.